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Abstract  
Background:  We aimed to study the retinal morphological findings associated with 
exudative age-related macular degeneration (AMD) and their association with visual 
prognosis. 
Methods:  We retrospectively reviewed the medical records of 96 consecutive patients 5 
(96 eyes) with exudative AMD.  Retinal structural changes were examined using optical 
coherence tomography (OCT). 
Results:  Initial OCT examination showed cystoid macular edema in 18 eyes (18.8%), 
fibrin exudate in 56 eyes (58.3%), and hyperreflective foci within the neurosensory retina 
in 78 eyes (81.3%).  Upon initial examination, an external limiting membrane (ELM) line 10 
was detected under the fovea in 64 eyes (66.7%).  Using Pearson’s correlation analyses, 
final visual acuity (VA) was correlated with initial VA (r = 0.61, p < 0.001), age (r = 0.34, p 
< 0.001), initial total foveal thickness (r = 0.41, p < 0.001), presence of hyperreflective foci 
(r = 0.40, p < 0.001), and detection of a foveal ELM line (r = 0.55, p < 0.001).  After 
multiple regression analysis, final VA correlated with initial VA (r = 0.48, p < 0.001), initial 15 
presence of hyperreflective foci (r = 0.23, p = 0.054), and detection of a foveal ELM line (r 
= 0.36, p = 0.008). 
Conclusions:  In eyes with exudative AMD, final VA was most correlated with initial VA.  
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In addition, the initial integrity of the foveal outer retina was partially correlated with the 
visual prognosis.  The initial ELM condition was associated with good final VA, while the 
initial presence of hyperreflective foci in the foveal neurosensory retina was associated 
with poor final VA. 
 5 
Keywords:  age-related macular degeneration, external limiting membrane, 
hyperreflective foci, optical coherence tomography, polypoidal choroidal vasculopathy 
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Introduction  
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide in 
individuals aged more than 50 years [1].  Although treatment for the disease has 
progressed dramatically after the development of anti-vascular endothelial growth factor 
(VEGF) therapy, not all patients achieve good vision [2-4].  A combination of 5 
photodynamic therapy (PDT) and anti-VEGF therapy is a promising option [5], but it 
might not markedly alter the prognosis of AMD [6].  Considering both the physical and 
financial costs of treatment [7], prediction of the visual prognosis at the patients’ initial 
visits would be very useful to both patients and clinicians. 
     A more detailed evaluation of retinal structure and function is needed to predict 10 
visual prognosis [8].  For this purpose, we have been trying to make the best use of 
optical coherence tomography (OCT).  Current models of commercially available 
spectral-domain OCT instruments provide fine images (up to 5-µm resolution) of the 
retinal structure [9,10].  Using spectral-domain OCT, Hayashi et al. showed a correlation 
between retinal structure and function in eyes with AMD that had undergone PDT [11].  15 
In short, the status of the junction between the inner and outer segments of the 
photoreceptors (IS/OS) [12,13], which is considered to reflect photoreceptor integrity, is 
associated with visual acuity (VA) [14].  Other authors have confirmed the association of 
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IS/OS status with VA [15] and with retinal sensitivity as measured using microperimetry 
[16].  In addition to IS/OS, the status of the external limiting membrane (ELM) has also 
been reported to be a good indicator of visual function in eyes with AMD [17].  
Evaluation of alterations in these retinal layer patterns at the time of the initial 
examination provides more detailed information about the retinal status [8,18,19]. 5 
     In addition to the retinal layer pattern, the presence of hyperreflective foci 
represents another possible predictive factor of VA [18].  Hyperreflective foci are 
reported to be present in diabetic macular edema [20], retinal vein occlusion [21], and 
AMD [18], and have been suggested to be subclinical features of lipoprotein 
extravasation, which implies blood-retinal barrier impairment.  Results consistent with 10 
this finding have been reported by other authors; the presence of hyperreflective foci is 
associated with hard exudate deposition [22].  The breakdown of the blood-retinal 
barrier as well as the accumulation of hard exudates would both be detrimental to eyes 
with AMD [18]. 
     Based on this structure-function relationship, we hypothesized that there might be a 15 
correlation between the pretreatment structure of eyes with AMD, and the visual 
prognosis.  However, to date, limited information is available about predictive factors of 
visual prognosis among the features obtained from initial OCT sections in exudative AMD 
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[23-25].  In the study reported herein, we longitudinally investigated OCT images of 
eyes with AMD throughout the course of anti-VEGF therapy and examined the 




Material and methods  
For this observational study, we retrospectively reviewed the medical records of 96 
consecutive patients (96 eyes) with exudative AMD who were seen by the Macula 
Service in the Department of Ophthalmology at Kyoto University Hospital between 10 
January 2008 and October 2009.  Inclusion criteria included: (1) symptomatic subfoveal 
AMD, (2) the presence of choroidal neovascularization (CNV) beneath the foveal center, 
(3) the presence of macula-related exudative or hemorrhagic features, and (4) a 
minimum follow-up of 12 months after the initial visit.  The current study included eyes 
with typical AMD and those with polypoidal choroidal vasculopathy (PCV).  The 15 
diagnosis of PCV was based on indocyanine green angiography, which reveals a 
branching vascular network that terminates in polypoidal swelling.  When both eyes met 
the inclusion criteria, only the eye with the more active lesion was included in the current 
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study.  Eyes with other macular abnormalities (i.e., pathologic myopia, retinal 
angiomatous proliferation, idiopathic CNV, presumed ocular histoplasmosis, angioid 
streaks, or other secondary CNV) and those with senile cataracts that resulted in 
poor-quality OCT images were excluded from the current study.  This study was 
approved by the Institutional Review Board at the Kyoto University Graduate School of 5 
Medicine and adhered to the tenets of the Declaration of Helsinki. 
     At the initial visit, each patient underwent a comprehensive ophthalmologic 
examination, including measurement of best-corrected VA (using the Landolt C test), 
determination of intraocular pressure, indirect ophthalmoscopy, slit-lamp biomicroscopy 
with a contact lens, spectral-domain OCT (Spectralis HRA+OCT; Heidelberg Engineering, 10 
Heidelberg, Germany), and fluorescein and indocyanine green angiography (HRA2; 
Heidelberg Engineering).  At each scheduled follow-up visit, each patient underwent a 
complete ophthalmologic examination, including VA measurement, slit-lamp 
biomicroscopy, indirect fundus ophthalmoscopy, and OCT examination.  Fluorescein 
and indocyanine green angiography were performed as deemed necessary. 15 
     After the initial visit, each eye was treated based on disease activity and VA.  Eyes 
with exudative AMD were treated either with PDT combined with intravitreal injection of 
an anti-VEGF agent, or with intravitreal injections of anti-VEGF agents alone.  After the 
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initial combined therapy, each eye was considered for retreatment with the combined 
therapy every 3 months if the eye exhibited residual or recurrent polypoidal lesions upon 
indocyanine green angiography.  In eyes treated with intravitreal injections of anti-VEGF 
agents alone, additional injections were administered on an as-needed basis.   
     In the current study, we evaluated the OCT images obtained from all eligible 5 
patients both quantitatively and qualitatively.  In both the initial and final OCT images, we 
measured total foveal thickness, defined as the distance between the vitreoretinal 
interface and the retinal pigment epithelium (Figure 1a).  Furthermore, we examined the 
IS/OS line and the ELM to assess outer foveal photoreceptor layer integrity.  The status 
of the IS/OS line and the ELM line under the fovea was defined as either complete or 10 
incomplete.  OCT images in eyes with exudative AMD often exhibited subretinal fluid 
and hemorrhages beneath the neurosensory retina.  In addition, most OCT images 
revealed morphological changes in the neurosensory retina.  Cystoid spaces and 
hyperreflective foci were seen in many cases within the neurosensory retina.  Fibrin 
derived from active CNV or polypoidal lesions was observed as amorphous 15 
hyperreflective material, not only in the subretinal space but also within the neurosensory 
retina.  Using horizontal and longitudinal OCT sections, we evaluated whether cystoid 
macular edema, hyperreflective foci, and fibrin exudates were seen within the 1 mm × 1 
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mm area around the fovea (Figure 1b). 
     Statistical analysis was performed using software designed for this purpose (IBM 
SPSS Statistics Desktop, version 19.0.0; IBM Japan, Tokyo, Japan).  All values are 
presented in terms of means and standard deviation.  Best-corrected VA was converted 
to a logarithm of the minimum angle of resolution (logMAR) equivalent for statistical 5 
analysis.  Values in typical AMD and PCV were compared using the Student’s t-test.  
Bivariate relationships were analyzed using the Pearson’s correlation coefficient or the 
Spearman rank correlation coefficient.  Stepwise forward multivariate linear regression 
analyses were also performed to evaluate the contribution of each initially identifiable 




In the current study, 96 eyes from 96 patients (72 men and 24 women) with exudative 
AMD who were 57–90 years of age (mean, 73.2 ± 8.5 years) were examined (Table 1).  15 
Of these 96 eyes, 61 had PCV and 35 had typical AMD.  The mean initial VA (logMAR) 
and foveal thickness were 0.58 ± 0.49 and 422.5 ± 255.9 µm, respectively; there were no 
significant differences in these parameters between eyes with typical AMD or PCV (p = 
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0.889, p = 0.787).  Active CNV lesions were treated with intravitreal injections of 
anti-VEGF agents in 38 eyes, and with PDT combined with anti-VEGF agents in 37 eyes.  
No treatments were performed in 21 eyes.  The mean number of injections was 4.7 ± 
3.2 and mean number of PDT treatments was 1.7 ±1.0.  The mean duration from the 
final treatment to the final examination was 13.4 ± 9.4 months.  The mean follow-up 5 
period was 24.6 ± 5.7 months. 
     At the initial visit, all eyes exhibited exudative changes beneath the neurosensory 
retina derived from active CNV (subretinal fluid and hemorrhage).  In addition, most 
OCT images revealed morphological changes within the neurosensory retina.  Cystoid 
macular edema was observed in 18.8% of eyes.  Cystoid spaces were usually observed 10 
within neurosensory retinas that were in direct contact with the underlying type 2 CNV, 
whereas detached retinas were rarely seen in any of the cystoid spaces.  In 58.3% of 
eyes, OCT revealed that the fibrin exudate was an amorphous hyperreflective material 
within the subretinal space.  Fibrin, which was often seen just over the underlying active 
type 2 CNV or polypoidal lesions, often appeared to infiltrate the overlying neurosensory 15 
retina, especially in the outer aspect, resulting in a lack of IS/OS or ELM lines.  In these 
eyes, the ELM seemed to work in some instances as a blocking agent against the 
exudates (Figure 2).  In 81.3% of eyes, intraretinal hyperreflective foci were seen within 
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the neurosensory retina.  Intraretinal hyperreflective foci were frequently seen 
throughout the entire outer retina, not only outside but also beyond the ELM (Figures 1 
and 2).  In our patients, the integrity of the inner and outer segments of the foveal 
photoreceptor cells appeared to be compromised due to exudative change from the CNV.  
At the initial examination, foveal ELM was seen in 66.7% of the eyes examined, whereas 5 
foveal IS/OS was seen in only 22.9% of the eyes examined.  
     Table 2 shows the correlations of initial VA with other measurements obtained at the 
initial examination.  Both the total foveal thickness and the presence of cystoid macular 
edema were correlated with initial VA (r = 0.39, p < 0.001; r = 0.39, p < 0.001).  In 
addition, foveal IS/OS and ELM were also correlated with initial VA (r = 0.35, p < 0.001; r 10 
= 0.48, p < 0.001). 
     At the final examination, the mean total thickness was significantly reduced to 305.4 
± 224.9 µm (p < 0.001), while cystoid macular edema was still seen in 11.5% of the eyes.  
Despite treatment, restoration of the integrity of the outer photoreceptor layer was limited.  
Complete detection of the IS/OS and ELM lines was achieved in only 29.1% and 54.2% 15 
of eyes, respectively.  Table 3 shows the correlations between final VA and other 
measurements obtained at the final examination.  The total foveal thickness and 
presence of cystoid macular edema were correlated with poor final VA (r = 0.27, p < 
Morphological Findings in AMD. Akagi-Kurashige, et al. Page 12 
0.001; r = 0.33, p < 0.001), whereas detection of foveal IS/OS and ELM lines was 
correlated with good final VA (r = 0.57, p < 0.001; r = 0.58, p < 0.001).  There were no 
differences in final VA between eyes with typical AMD and PCV (p = 0.149). 
     Table 4 shows the correlations of final VA with measurements obtained at the initial 
examination (Pearson’s correlation analyses); of these, initial VA showed the closest 5 
correlation with final VA (r = 0.61, p < 0.001).  Age (r = 0.34, p < 0.001), total foveal 
thickness (r = 0.40, p < 0.001), and the presence of hyperreflective foci or cystoid 
macular edema (r = 0.26, p = 0.012) at the initial visit also correlated with final VA.  In 
addition, the initial detection of the foveal IS/OS and ELM lines was correlated with final 
VA (r = 0.42, p < 0.001; and r = 0.55, p < 0.001, respectively).  However, there were no 10 
differences in final VA between treatment types (p = 0.637).  Table 5 shows the 
correlations between VA and the measurements obtained at the initial examination in 
each group, stratified by treatment.  In each group, while the correlations had similar 
tendencies, some were not statistically significant, perhaps due to the small number of 
eyes. 15 
     Table 6 shows the correlations between final VA and the measurements obtained at 
the initial examination after multiple regression analysis.  By multiple regression 
analysis, final VA was correlated with initial VA (r = 0.48, p < 0.001) and the detection of a 
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foveal ELM line (r = 0.33, p = 0.008).  The initial presence of cystoid macular edema 
was associated with initial poor VA (r = 0.39, p < 0.001), but had no significant correlation 
with final visual function.  On the other hand, the initial presence of hyperreflective foci 
had no significant correlation with initial VA (r = 0.11, p = 0.261), but showed a marginal 




In the present study, we evaluated the morphological findings of the retina associated 
with exudative AMD and found that initial ELM status and the presence of hyperreflective 10 
foci are associated with the visual prognosis.  Although the predictive power was inferior 
to that of initial VA, these parameters at the time of the initial examination can be of help 
in predicting the visual prognosis.  
     Although both ELM and IS/OS status were correlated with visual prognosis in 
bivariate relationship analysis, the multiple regression model showed that only ELM, and 15 
not IS/OS status, contributes to visual prognosis.  This finding can be explained, at least 
in part, by the previously held notion that the IS/OS change is too sensitive for use in the 
evaluation of diseases that cause severe retinal damage, such as exudative AMD [17].  
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In the current study, of the 96 eyes, IS/OS and ELM lines just beneath the fovea were 
confirmed in 22 eyes (22.9%) and 64 eyes (66.7%), respectively, suggesting that the 
IS/OS is impaired relatively early in the course of AMD.  In fact, the ELM line was always 
confirmed when an IS/OS line was detectable.  This finding is consistent with the 
findings of previous studies that examined other macular diseases (e.g., macular hole 5 
[26], retinal detachment [27]).  Taken together, these facts indicate that the IS/OS is 
more susceptible and is disrupted in earlier stages than is the ELM.  Photoreceptor 
damage appears as disruption of the IS/OS at first and subsequently of the ELM in these 
conditions, so the evaluation of the ELM and of the IS/OS depends on the severity of the 
disease.  10 
     An intact ELM might indicate the preservation of the anatomic barrier as well as 
photoreceptor integrity.  The ELM consists of the zonula adherens between the Müller 
cells and the photoreceptors at the base of the outer segments; this junction is not as 
tight as that of the zonula occludens, but it does limit the movement of large molecules 
[28].  As shown in Figure 2, some eyes demonstrated termination of subretinal fibrin at 15 
the ELM border, suggesting that the ELM actually acts as a barrier to subretinal proteins 
or lipids.  The prevention of molecular invasion and the subsequent retinal fluid 
accumulation would have beneficial effects on visual prognosis, providing another reason 
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to study ELM status and its relationship with visual prognosis. 
     The present study also showed that hyperreflective foci could possibly predict 
vision, as the presence of hyperreflective foci was negatively associated with the visual 
prognosis.  Although hyperreflective foci are not a functional retinal component and 
subfoveal hard exudate accumulation was not a cause of poor visual prognosis, we 5 
believe that the presence of hyperreflective foci are a hallmark of blood-retinal barrier 
function, and thus reflect visual outcome.  Hyperreflective foci were visible before 
treatment in many eyes (81.3%) but tended to disappear as the exudative changes 
improved (40.6% at final examination).  An earlier report also suggested that the 
presence of hyperreflective foci reflects blood-retinal barrier impairment [20].  It is 10 
possible that eyes with hyperreflective foci at the initial examination had more active CNV 
and more severe blood-retinal barrier damage. In other words, the small percentage of 
cases without hyperreflective foci had milder CNV and milder blood-retinal barrier 
damage; this difference in the degree of blood-retinal barrier damage might have affected 
visual prognosis. 15 
     There are many limitations to the present study, including the retrospective study 
design, the relatively small study population from a single institution, and the variety of 
treatment regimens used.  While the heterogeneity in disease types might have affected 
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the results, there were no differences in initial and final VA between eyes with typical 
AMD and PCV.  In the current study, eyes with exudative AMD were treated with 
intravitreal injections of anti-VEGF agents with or without PDT.  When stratified by 
treatment, the correlations showed similar tendencies, some of which were not 
statistically significant, perhaps due to the small number of eyes.  Eyes treated with 5 
combination therapy showed the lowest association between the initial condition of the 
outer retina and final VA.  While the phototoxic effect of PDT might be involved in this 
low correlation, the exact reason is not unclear.  It is possible that the treatment regimen 
used have some effect on the visual prognosis. 
     Another limitation is the very nature of OCT examinations.  The device used 10 
depicts only a difference in light reflectance.  Furthermore, we are not completely sure 
what the presence of an intact ELM or hyperreflective foci implies. Both of these are 
issues that need to be addressed in future studies.  Although initial VA is most strongly 
associated with the visual prognosis, the initial condition of the outer retina may be of 
help in predicting the visual prognosis in eyes with AMD.  This information will help 15 
clinicians provide appropriate information to their patients.  A further prospective study is 
necessary to establish the factors that predict visual prognosis in eyes with exudative 
AMD. 
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Figure Legends 
Fig. 1.  A. Horizontal image of the fovea obtained using optical coherence tomography 
(OCT) of an eye with active exudative age-related macular degeneration.  Using an 
initial OCT image, 3 measurements were made in the fovea, including total foveal 
thickness, continuity of the external limiting membrane (ELM; white arrowheads), and 5 
continuity of the junction between the inner and outer photoreceptor segments (IS/OS; 
yellow arrowheads).  B. Cross-sectional image of the foveal region obtained using OCT.  
Using these OCT sections, we determined whether cystoid macular edema (white arrow), 
hyperreflective foci (yellow arrows), or fibrin exudate (yellow arrowheads) were seen 
within the 1 mm × 1 mm square area around the fovea. 10 
 
Fig. 2.  Changes in retinal structure seen in polypoidal choroidal vasculopathy.  A. 
Initial fluorescein angiography.  B. Initial indocyanine green angiography shows 
numerous polypoidal lesions.  C. Initial fundus photograph exhibiting reddish-orange 
nodules and an adjacent detachment of the pigment epithelium.  D. Fundus photograph 15 
at final visit.  E. Sectional image obtained using optical coherence tomography (OCT) at 
the initial visit.  Numerous hyperreflective foci (yellow arrows), as well as subretinal 
fluid/fibrin (yellow asterisk) are seen.  The fibrin appears to have infiltrated the outer 
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retina but appears to be blocked at the external limiting membrane (white arrowheads).  
The structure of the neurosensory retina seems to be relatively well preserved.  The line 
of the external limiting membrane is detectable under the fovea.  The visual acuity was 
0.3 by the Landolt chart.  F. Sectional image obtained using OCT at the final visit.  The 
visual acuity was 0.9 by the Landolt chart.  5 
 
Fig. 3.  Changes in retinal structure seen in typical age-related macular degeneration.  
A. Initial fluorescein angiography shows minimally classic choroidal neovascularization 
(CNV).  B. Initial indocyanine green angiography.  C. Fundus photograph at initial visit 
shows subfoveal exudate with surrounding subretinal hemorrhage.  D. Fundus 10 
photograph at final visit shows subfoveal fibrous tissue.  E. Sectional image obtained 
using optical coherence tomography (OCT) at the initial visit.  Hyperreflective foci 
(yellow arrows) and cystoid macular edema (white arrow) are seen within the 
neurosensory retina.  Subretinal fluid/fibrin (yellow asterisk) is seen subfoveally.  The 
line of the external limiting membrane is not detectable under the fovea.  Visual acuity 15 
was 0.2 by the Landolt chart.  F. Sectional image obtained using OCT at the final visit.  
Sectional OCT image at 20 months shows thick subfoveal deposit.  The visual acuity 
was 0.1 by the Landolt chart.  
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Table 1. Characteristics of the study population 
Number of eyes 96 
Age (years; mean [SDa]) 73.2 (8.5) 
Gender (women/men) 24/72 
Initial examination  
Visual acuity (logMARb; mean [SD]) 0.58 (0.49) 
Total foveal thickness (µm; mean [SD]) 422.5 (255.9) 
Detection of IS/OSc under the fovea (complete/incomplete) 22/74 
Detection of ELMd under the fovea (complete/incomplete) 64/32 
Cystoid macular edema, number of eyes (%) 18 (18.8) 
Hyperreflective foci, number of eyes (%) 78 (81.3) 
Fibrin, number of eyes (%) 56 (58.3) 
Follow-up (months; mean [SD]) 24.6 (5.7) 
Treatment  
Photodynamic therapy (%) 37 (38.5) 
Anti-vascular endothelial growth factor therapy (%) 38 (39.6) 
Final examination  
Visual acuity (logMAR; mean [SD]) 0.65 (0.61) 
Total foveal thickness (µm; mean [SD]) 305.4 (224.9) 
Detection of IS/OS under the fovea (complete/incomplete) 28/68 
Detection of ELM under the fovea (complete/incomplete) 52/44 
Cystoid macular edema, number of eyes (%) 11 (11.5) 
Hyperreflective foci, number of eyes (%) 39 (40.6) 
Fibrin, number of eyes (%) 22 (22.9) 
aSD, standard deviation; blogMAR, logarithm of the minimum angle of resolution; 
cIS/OS, junction between the inner and outer photoreceptor segments; dELM, 
external limiting membrane 
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Table 2. Association between initial visual acuity and other measurements 
obtained at initial examination 
 r p value 
Age 0.20 0.048 
Gender 0.03 0.782 
Diabetes mellitus 0.04 0.720 
Hypertension 0.08 0.413 
Smoking 0.09 0.370 
Type of disease 0.03 0.787 
Total foveal thickness  0.39 <0.001 
Cystoid macular edema 0.39 <0.001 
Hyperreflective foci  0.11 0.261 
Fibrin 0.05 0.603 
Detection of IS/OSa under the fovea 0.35 <0.001 
Detection of ELMb under the fovea  0.48 <0.001 
aIS/OS, junction between the inner and outer photoreceptor segments; bELM, 
external limiting membrane 
Morphological Findings in AMD. Akagi-Kurashige, et al. Page 27 
 
Table 3. Association between final visual acuity and other measurements 
obtained at final examination 
 r p value 
Age 0.34 <0.001 
Gender 0.03 0.770 
Follow-up period  0.03 0.787 
Diabetes mellitus 0.06 0.589 
Hypertension 0.02 0.827 
Smoking 0.01 0.908 
Total foveal thickness  0.27 <0.001 
Cystoid macular edema 0.33 <0.001 
Hyperreflective foci  0.16 0.120 
Fibrin 0.12 0.258 
Detection of IS/OSa under the fovea 0.57 <0.001 
Detection of ELMb under the fovea 0.58 <0.001 
aIS/OS, junction between the inner and outer photoreceptor segments; bELM, 
external limiting membrane 
*Fisher's Least Significant Difference test 
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Table 4. Associations between final visual acuity and measurements obtained at 
initial examination and during treatment 
 r p value 
Age 0.34 <0.001 
Gender 0.03 0.770 
Diabetes mellitus 0.06 0.589 
Hypertension 0.02 0.827 
Smoking 0.01 0.908 
Type of disease 0.15 0.149 
Visual acuity (logMARa) 0.61 <0.001 
Total foveal thickness  0.40 <0.001 
Cystoid macular edema 0.34 <0.001 
Hyperreflective foci  0.26 0.012 
Fibrin 0.06 0.513 
Detection of IS/OSb under the fovea 0.42 <0.001 
Detection of ELMc under the fovea  0.55 <0.001 
Treatment - 0.637* 
alogMAR, logarithm of the minimum angle of resolution; bIS/OS, junction between 
inner and outer segments of the photoreceptors; cELM, external limiting 
membrane 
*Fisher's Least Significant Difference test 
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Table 5. Association between final visual acuity and other measurements obtained at initial 












(n = 38) 
 r p value r p value r p value 
Age 0.50 0.022 0.32 0.058 0.27 0.106 
Gender 0.40 0.073 0.23 0.177 0.03 0.869 
Diabetes mellitus 0.09 0.712 0.27 0.101 0.22 0.175 
Hypertension 0.13 0.576 0.15 0.367 0.04 0.793 
Smoking 0.02 0.926 0.12 0.481 0.14 0.397 
Visual acuity (logMARb) 0.76 <0.001 0.48 0.003 0.62 <0.001 
Total foveal thickness  0.45 0.042 0.36 0.029 0.40 0.013 
Cystoid macular edema NA NA 0.26 0.117 0.49 0.002 
Hyperreflective foci  0.38 0.090 0.01 0.968 0.28 0.093 
Fibrin 0.01 0.957 0.07 0.666 0.12 0.469 
Detection of IS/OSc 
under the fovea 
0.47 0.034 0.32 0.055 0.46  0.004 
Detection of ELMd under 
the fovea  
0.71 <0.001 0.26 0.117 0.65 <0.001 
aVEGF, vascular endothelial growth factor; blogMAR, logarithm of the minimum angle of 
resolution; cIS/OS, junction between inner and outer photoreceptor segments; dELM, 
external limiting membrane 
No eyes exhibited cystoid macular edema at the initial visit in the no treatment group. 
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Table 6. Association between final visual acuity and measurements obtained at initial 
examination, evaluated by multiple regression analysis 
 Partial regression coefficient p value 
Age  0.01 0.036 
Gender  NAa - 
Diabetes mellitus NA - 
Hypertension NA - 
Smoking NA - 
Type of disease NA - 
Visual acuity (logMARb) 0.48 <0.001 
Total foveal thickness <0.01 0.292 
Cystoid macular edema 0.02 0.856 
Hyperreflective foci 0.23 0.054 
Fibrin NA - 
Detection of IS/OSc under the fovea 0.13 0.279 
Detection of ELMd under the fovea  0.33 0.008 
aNA, not applicable; blogMAR, logarithm of the minimum angle of resolution; cIS/OS, 
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